5-HTP CR 60 T

Xymogen

$48.99
(No reviews yet) Write a Review
SKU:
XY-5HTP-CR100
Availability:
Usually Ships in 48 to 72 Hours
Already Registered?
How to Gain Access to Store?

5-HTP CR 60 T by Xymogen

5-HTP CR 60 T by Xymogen is a slow-release supplement that supports the healthy biosynthesis of serotonin, a key neurotransmitter important for regulating mood and behavior.* By enhancing serotonin levels, 5-HTP CR promotes a positive outlook, supports a normal appetite, and helps maintain restful sleep patterns.* Serotonin is also converted into melatonin, supporting improved sleep quality by increasing the length of rapid eye movement (REM) sleep.* This supplement is well-absorbed in the intestine and can cross the blood-brain barrier, providing effective support.* 5-HTP CR is drug-free and may help address symptoms like difficulty sleeping, low mood, and overeating.* In children, it can help modulate arousal levels and promote peaceful sleep.* With its slow-release formulation, 5-HTP CR offers sustained support for mood and overall well-being.*

Who Should Consider 5-HTP CR 60 T by Xymogen?

5-HTP CR 60 T by Xymogen may support your health if you:

  • struggle with low mood
  • are frequently anxious
  • have trouble with eating habits
  • have trouble sleeping or experience disturbed sleep patterns

5-HTP CR 60 T by Xymogen—Effects?

5-HTP CR 60 T by Xymogen may:

  • promote a positive mood and outlook
  • enhance sleep quality
  • regulate appetite
  • provide healthy biosynthesis of serotonin

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about 5-HTP CR 60 T by Xymogen.

Recommendation:
Xymogen suggests taking one 5-HTP CR tablet, up to two times daily, with a meal, or as directed by your healthcare professional. Do not exceed the recommended dose.


Serving Size: 1 Tablet
Servings Per Container: 60
 
Amount Per Serving:
Calcium (as dicalcium phosphate dihydrate) 27 mg
5-HTP (5-Hydroxytryptophan)(from Griffonia simplicifolia) (seed) 100 mg

Other Ingredients: Hydroxypropyl methylcellulose, hydroxypropyl cellulose, ascorbyl palmitate, silica, and coating (tapioca maltodextrin, sunflower lecithin, palm oil, and guar gum).
 
Caution: Consult your healthcare professional prior to use if you have, or suspect you have, a medical condition or are taking prescription drugs for depression, migraines, Parkinson’s disease, or psychiatric disorders. Not for use by children.

Storage: Keep 5-HTP CR tightly closed in a cool, dry place.

Does Not Contain: Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, and artificial preservatives.
Click here to view Data Sheet


LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited.

References:

  1. Juhl JH. (1998 Oct) Fibromyalgia and the serotonin pathway. Altern Med Rev. 3(5):367-75. 
  2. Gutknecht L, Jacob C, Strobel A, et al. (2007 Jun)Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol;10(3):309-20.
  3. Birdsall TC ( 1998 Aug) 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 3(4):271-80.
  4. Agren H, Reibring L, Hartvig P, et al. (1991) Low brain uptake of L-[11C]5- hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers. Acta Psychiatr Scand; 83(6):449-55.
  5. Zmilacher K, Battegay R, Gastpar M. (1988) L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression. Neuropsychobiology. 20(1):28-35.
  6. Caruso I, Sarzi Puttini P, Cazzola M, et al. (1990 May-Jun) Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res. 18(3):201-09.
  7. Puttini S, Caruso I. (1992 Apr) Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res. 20(2):182-89.